The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease

Hepatogastroenterology. 2005 Nov-Dec;52(66):1832-5.

Abstract

Background/aims: The apolipoprotein E (apo E) gene is known to affect plasma lipoprotein-lipid levels, and lipoprotein (a) [Lp(a)] is an atherogenic lipoprotein that is negatively correlated with triglyceride level. The purpose of this study was to investigate the relationship between the apo E genotype, plasma Lp(a) level, and fatty liver.

Methodology: A cross-sectional study was performed on 711 subjects who were diagnosed as having fatty liver by ultrasonography and on 711 sex- and age-matched control subjects. Apo E genotype, plasma Lp(a) concentrations, and serum levels of total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol were measured.

Results: Fatty liver subjects were found to have significantly higher triglyceride, and lower HDL-cholesterol levels. According to the multivariate logistic regression analysis, the odds ratios for fatty liver were 2.254 (95% CI 1.697-2.993) for hypertriglyceridemia, 1.841 (95% CI 1.449-2.339) for a high LDL-cholesterol level, 1.509 (95% CI 1.112-2.046) for a low HDL-cholesterol level, and 0.364 (95% CI 0.194-0.684) for a high HDL-cholesterol level. The odds ratios of epsilon4 and a high plasma Lp(a) level for fatty liver were 0.631 (95% CI 0.468-0.850) and 0.607 (95% CI 0.470-0.784) respectively.

Conclusions: Our results suggest that the epsilon4 allele of apo E and plasma Lp(a) concentration may be associated with the pathogenesis of fatty liver.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Distribution
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism*
  • Case-Control Studies
  • Cross-Sectional Studies
  • Disease Progression
  • Fatty Liver / epidemiology
  • Fatty Liver / genetics*
  • Fatty Liver / pathology
  • Female
  • Gene Expression Regulation
  • Genetic Markers / genetics
  • Humans
  • Lipoprotein(a) / genetics
  • Lipoprotein(a) / metabolism*
  • Liver Function Tests
  • Logistic Models
  • Male
  • Middle Aged
  • Odds Ratio
  • Polymorphism, Genetic*
  • Probability
  • Prognosis
  • Reference Values
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Sex Distribution

Substances

  • Apolipoproteins E
  • Genetic Markers
  • Lipoprotein(a)